Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glycopyrrolate topical - Dermira

Next Previous
X
Search
Drug Profile

Glycopyrrolate topical - Dermira

Alternative Names: DRM-04B; DRM04; DRM04 Topical Wipes; Glycopyrronium cloth; Glycopyrronium topical wipes; Glycopyrronium tosylate; Glycopyrronium tosylate hydrate; Glycopyrronium tosylate monohydrate; QBREXZA; Qbrexza™ Cloth; Rapifort; Rapifort® Wipes 2.5%

Latest Information Update: 08 Sep 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stiefel Laboratories
  • Developer Dermira; Maruho
  • Class Antiasthmatics; Antispasmodics; Antiulcers; Pyrrolidines; Quaternary ammonium compounds; Skin disorder therapies; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hyperhidrosis

Most Recent Events

  • 06 Sep 2023 Glycopyrrolate topical licensed to Maruho in Brunei, Cambodia, Hong Kong, Indonesia, Laos, Macau, Malaysia, Myanmar, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
  • 14 Feb 2022 Journey Corporation acquires global rights of QBREXZA® from Dermira
  • 14 Feb 2022 Journey Medical Corporation enters into an exclusive licensing agreement with Mahuro for manufacturing and marketing of RapifortTM wipes 2.5%

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top